Business Context and Reporting Period
This Form 8-K filing by Anthem, Inc. (now Elevance Health, Inc.) covers the date of May 15, 2019. The report details the outcomes of the Company's Annual Meeting of Shareholders held on this date, specifically focusing on corporate governance changes and the election of directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance events and does not contain financial performance data.
Material Changes and Corporate Actions
- Elimination of Classified Board: Shareholders approved amendments to the Articles of Incorporation and Bylaws to eliminate the classified board structure. This change is effective when permitted under contractual obligations with the Blue Cross and Blue Shield Association (BCBSA).
- Director Elections: Shareholders elected nominees Bahija Jallal and Elizabeth E. Tallett to three-year terms expiring in 2022. Both received significant majority support, though Ms. Tallett faced higher opposition than Ms. Jallal.
- Shareholder Proposal: A shareholder proposal to elect each director annually (subject to BCBSA obligations) was approved by a majority of votes cast.
- Executive Compensation: The advisory vote on executive compensation was approved, though it received a notable minority of "Against" votes.
- Auditor Ratification: The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2019 was ratified.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors. The primary contingency noted is that the transition to an annual director election schedule is dependent on the Company's contractual obligations with the BCBSA.
Investor Verification Checklist
- Verify the specific timeline for the full implementation of the annual director election schedule based on BCBSA contract terms.
- Review the full text of the amended Articles of Incorporation (Exhibit 3.1) and Bylaws (Exhibit 3.2) for detailed governance provisions.
- Monitor future filings for the first annual election of directors following the removal of the classified board structure.
- Assess the level of shareholder dissent on the executive compensation vote (approximately 6.5% against) as an indicator of governance sentiment.